Marielle Weintraub, Ph.D.

Director of Scientific Strategy, OTC/GMP Testing, EFCT- Madison

Dr. Marielle Weintraub is the Director of Scientific Strategy for OTC/GMP Testing at Eurofins-Madison, WI. In this role, Dr. Weintraub is tasked with supporting clients that are require testing programs developed for OTC, API, homeopathic and dietary supplement products. These testing programs may include utilizing risk-assessment, method development, validation, verification, release testing and stability studies, including accelerated, long-term, in-use, and photostability. Before returning to Eurofins in 2022, Dr. Weintraub spent three years working in quality and regulatory roles, in the hemp/cannabis industry, focusing on supplements and personal care products. Dr. Weintraub is very active in many OTC, dietary supplement, and natural product industry trade associations. For instance, she has been elected to serve on the Technical Programming Council for AOAC International and is a member of CHPA's Quality and Manufacturing Committee. Dr. Marielle Weintraub earned her M.S. and Ph.D. in Behavioral Neuroscience (Psychoneuroimmunology) focusing her research on Alzheimer’s disease pathology.